Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment

CONCLUSIONS: Low-dose AD04 has the potential to be a safe treatment option for subjects with AUD and ALD, indicating the need for an RCT for this specific cohort. Such a trial would pave the way for the design of a precision treatment for combined AUD with ALD.PMID:38521730 | DOI:10.1016/j.ejim.2024.03.017

Source: European Journal of Internal Medicine - March 23, 2024 Category: Internal Medicine Authors: Giovanni Addolorato Hannu Alho Paula Bresciani M De Andrade Otto Michael Lesch Lei Liu Bankole Johnson Source Type: research